SavedAdd your journal

Journals / Trends in pediatrics / 2021 / Cilt: 2 - Sayı: 1

Chryseobacterium indologenes as a Rare Pathogen of Bacteremia in Febrile Neutropenia

Elvan Çağlar ÇITAK
Fatih SAĞCAN
Begümhan DEMİR GÜNDOĞAN
Pages
43–46
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to the antimicrobial susceptibility test result, he was treated with cephaperazone/sulbactam.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chryseobacterium indologenes (C. indologenes) is nonmotile, oxidase-, and indole-positive gram-negative aerobic bacillus.
📊
Key Findings & Data:We report a neutropenic fever caused by C. indologenes in a 16-month-old boy who was treated due to the neuroblastoma.
💡
Conclusion & Impact:According to the antimicrobial susceptibility test result, he was treated with cephaperazone/sulbactam.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Chryseobacterium indologenes (C. indologenes) is nonmotile, oxidase-, and indole-positive gram-negative aerobic bacillus. Immunosuppression, comorbidities, use of broad-spectrum antibiotics are known risk factors for C. indologenes-related infections. We report a neutropenic fever caused by C. indologenes in a 16-month-old boy who was treated due to the neuroblastoma. According to the antimicrobial susceptibility test result, he was treated with cephaperazone/sulbactam.

🔖

Cite This Article

ÇITAK, E. Ç., SAĞCAN, F., GÜNDOĞAN, B. D. (2022). Chryseobacterium indologenes as a Rare Pathogen of Bacteremia in Febrile Neutropenia. Trends in pediatrics, Cilt: 2 - Sayı: 1, 43–46. https://ajindex.com/articles/598886

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Nemli SA, Demirdal T, Ural S. A case of healthcare associated pneumonia caused by Chryseobacterium indologenes in an immunocompetent patient. Case Rep Infect Dis. 2015;2015:483923
  2. Celkan T, Ozkan A, Apak H, Diren S, Can G, Yuksel L et al. Bacteremia in childhood cancer. J Trop Pediatr. 2002;48:373-7.
  3. Clinical and Laboratory Standards Institute (2014) Performance standards for antimicrobial susceptibility testing. Twenty-Fourth informational supplement. M100-S24. CLSI, Wayne, PA
  4. Chen FL, Wang GC, Teng SO, Ou TY, Yu FL, Lee WS. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases. J Microbiol Immunol and Infect. 2013;46: 425-32.
  5. Aslan S, Citak EC, Yis R, Degirmenci S, Arman D. Bacterial spectrum and antimicrobial susceptibility pattern of bloodstream infections in children with febrile neutropenia: experience of single center in southeast of Turkey. Indian J Microbiol. 2012;52:203-208
  6. Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial Susceptibility and Epidemiology of a Worldwide Collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J Clin Microbiol. 2004;42:445-8.
  7. Hsueh PR, Teng LJ, Yang PC, Ho SW, Hsieh WC, Luh KT. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis. 1997;16:568-74.
  8. Corbella M, Brandolini M, Cambieri P, et al. A catheter-related bloodstream infection caused by Chryseobacterium indologenes successfully treated with antibiotic-lock rescue therapy. New Microbiol. 2017 Jul;40(3):223-5
  9. Deng L, Li MF, Li YH, Yang JL, Zhou X. Chryseobacterium indologenes in four patients with leukemia. Transpl Infect Dis. 2015;17:583-7.
  10. Esposito S, Russo E, De Simone G, Gioia R, Noviello S, Vitolo M et al. Transient bacteraemia due to Chryseobacterium indologenes in an immunocompetent patient: a case report and literature review. J Chemother 2014;27:324-9.
  11. Cooper S, Levy I, Ben-Zvi H, Ashkenazi-Hoffnung L, Ben-Shimol S, Shachor-Meyouhas Y et al. Flavobacteriaceae Bacteremia in Children: A Multicenter Study. Pediatr Infect Dis J 2019;38:109